Antidepressant properties of substance P antagonists: Relationship to monoaminergic mechanisms?

Current Drug Targets: CNS and Neurological Disorders

Volumn 3, Issue 2, 2004, Pages 113-121

  Adell, Albert ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 5 [[2 [1 [3,5 BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY] 3 (4 FLUOROPHENYL) 4 MORPHOLINYL]METHYL] N,N DIMETHYL 1H 1,2,3 TRIAZOLE 4 METHANAMINE; ANTIDEPRESSANT AGENT; APREPITANT; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE; FLUOXETINE; INOSITOL PHOSPHATE; KAINIC ACID RECEPTOR; L 759274; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROKININ A; NEUROKININ B; NEUROPEPTIDE; PAROXETINE; PHOSPHOLIPASE C; PLACEBO; PREPROTACHYKININ; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; SUBSTANCE P ANTAGONIST; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOFOPITANT; BIOGENIC AMINE; NEUROKININ 1 RECEPTOR; SEROTONIN;

ANXIETY; BRAIN REGION; CLINICAL RESEARCH; CLINICAL TRIAL; DEPRESSION; DESENSITIZATION; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; IN VIVO STUDY; LOCUS CERULEUS; LONG TERM CARE; MONOAMINE NERVE CELL; MONOAMINERGIC SYSTEM; NAUSEA; NOCICEPTION; NONHUMAN; NORADRENERGIC NERVE; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SIDE EFFECT; TRANQUILIZING ACTIVITY; ANIMAL; BRAIN; BRAIN LEVEL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; TISSUE DISTRIBUTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; NEURONS; RECEPTORS, NEUROKININ-1; SEROTONIN; SUBSTANCE P; TISSUE DISTRIBUTION;

EID: 2642547366     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007043482516     Document Type: Review

References (133)

1. Maggi, C.A. Trends Pharmacol. Sci., 2000, 21, 173.
2. Krause, J.E.; Chirgwin, J.M.; Carter, M.S.; Xu, Z.S.; Hershey, A.D. Proc. Natl. Acad. Sci. USA, 1987, 84, 881.
3. Maggi, C A.; Schwartz, T.W. Trends Pharmacol. Sci., 1997, 18, 351.
4. Dietl, M.M.; Palacios, J.M. Brain Res., 1991, 539, 211.
5. Takeda, Y.; Chou, K.B.; Takeda, J.; Sachais, B.S.; Krause, J.E. Biochem. Biophys. Res. Commun., 1991, 179, 1232.
6. Beresford, I.J.; Birch, P J.; Hagan, R.M.; Ireland, S.J. Br. J. Pharmacol., 1991, 104, 292.
7. Gitter, B.D.; Bruns, R.F.; Howbert, J.J.; Waters, D.C.; Threlkeld, P.G.; Cox, L.M.; Nixon, J.A.; Lobb, K.L.; Mason, N.R.; Stengel, P.W. J. Pharmacol. Exp. Ther., 1995, 275, 737.
8. Fong, T.M.; Yu, H.; Strader, C.D. J. Biol. Chem., 1992, 267, 25668.
9. Sachais, B.S.; Snider, R.M.; Lowe, J.A.; Krause, J.E. J. Biol. Chem., 1993, 268, 2319.
10. Kramer, M.S.; Cutler, N.; Feighner, J.; Shrivastava, R.; Carman, J.; Sramek, J.J.; Reines, S.A.; Liu, G.; Snavely, D.; Wyatt-Knowles, E.; Hale, J.J.; Mills, S.G.; MacCoss, M.; Swain, C.J.; Harrison, T.; Hill, R.G.; Hefti, F.; Scolnick, E.M.; Cascieri, M.A.; Chicchi, G.G.; Sadowski, S.; Williams, A.R.; Hewson, L.; Smith, D.; Carlson, E.J.; Hardgreaves, R.J.; Rupniak, N.M.J. Science, 1998, 281, 1640.
11. Baker, K.G.; Halliday, G.M.; Hornung, J.P.; Geffen, L.B.; Cotton, R.G.; Törk, I. Neuroscience, 1991, 42, 757.
12. Sergeyev, V.; Hökfelt, T.; Hurd, Y. Neuroreport, 1999, 10, 3967.
13. Charara, A.; Parent, A. J. Chem. Neuroanat., 1998, 15, 111.
14. Amin, A.H.; Crawford, T.B.B.; Gaddum, J.H. J. Physiol. (London), 1954, 126, 596.
15. Arai, H.; Emson, P.C. Brain Res., 1986, 399, 240.
16. Otsuka, M.; Yoshioka, K. Physiol. Rev., 1993, 73, 229.
17. Halliday, G.; Harding, A.; Paxinos, G. In The Rat Nervous System, George Paxinos, Ed.; Academic Press: San Diego, 1995; pp. 929-974.
18. Ribeiro-da-Silva, A.; Hökfelt, T. Neuropeptides, 2000, 34, 256.
19. Marksteiner, J.; Saria, A.; Krause, J.E. Neuroscience, 1992, 51, 107.
20. Shults, C.W.; Quirion, R.; Chronwall, B.; Chase, T.N.; O'Donohue, T.L. Peptides, 1984, 5, 1097.
21. Warden, M.K.; Young, W.S. III. J. Comp. Neurol., 1988, 272, 90.
22. Harlan, R.E.; Garcia, M.M., Krause, J.E. J. Comp. Neurol., 1989, 287, 179.
23. Armstrong, D.M.; Pickel, V.M.; Joh, T.H. J. Comp. Neurol., 1981, 196, 505.
24. Campos, D.; Pereira, J.R.; Reinhardt, R.R. J. Clin. Oncol., 2001, 19, 1759.
25. Van Belle, S.; Lichinitser, M.R.; Navari, R.M.; Garin, A.M.; Decramer, M.L.; Riviere, A.; Thant, M.; Brestan, E.; Bui, B.; Eldridge, K.; De Smet, M.; Michiels, N.; Reinhardt, R.R.; Carides, A.D.; Evans, J.K.; Gertz, B.J. Cancer, 2002, 94, 3032.
26. Napier, T.C.; Mitrovic, I.; Churchill, L.; Klitenick, M.A.; Lu, X.-Y.; Kalivas, P. W. Neuroscience, 1995, 69, 59.
27. Gallagher, A.W.; Chahl, L.A.; Lynch, A.M. Brain Res. Bull., 1992, 29, 199.
28. Hurd, Y.L.; Keller, E.; Sotonyi, P.; Sedvall, G. J. Comp. Neurol., 1999, 411, 56.
29. Coveñas, R.; Martin, F.; Belda, M.; Smith, V.; Salinas, P.; Rivada, E.; Diaz-Cabiale, Z.; Narvaez, J.A.; Marcos, P.; Tramu, G.; Gonzalez-Baron, S. BMC Neuroscience, 2003, 4, 3.
30. Cooper, P.E.; Fernstrom, M.H.; Rorstad, O.P.; Leeman, S.E.; Martin, J.B. Brain Res., 1981, 218, 219.
31. Ma, Q.-P.; Bleasdale, C. Neuroreport, 2002, 13, 1809.
32. Hökfelt, T.; Arvidsson, U.; Cullheim, S.; Millhorn, D.; Nicholas, A.P.; Pieribone, V.; Seroogy, K.; Ulfhake, B. J. Chem. Neuroanat., 2000, 18, 75.
33. Yokota, Y.; Sasai, Y.; Tanaka, K.; Fujiwara, T.; Tsuchida, K.; Shigemoto, R.; Kakizuka, A.; Ohkubo, H.; Nakanishi, S. J. Biol. Chem., 1989, 264, 17649.
34. Hershey, A.D.; Krause, J.E. Science, 1990, 247, 958.
35. Mitsuhashi, M.; Ohashi, Y.; Shichijo, S.; Christian, C.; Sudduth-Klinger, J.; Harrowe, G.; Payan, D.G. J. Neurosci. Res., 1992, 32, 437.
36. Nakajima, Y.; Tsuchida, K.; Negishi, M.; Ito, S.; Nakanishi, S. J. Biol. Chem., 1992, 267, 2437.
37. Stacey, A.E.; Woodhall, G.L.; Jones, R.S.G. Neuroscience, 2002, 115, 575.
38. Stacey, A.E.; Woodhall, G.L.; Jones, R.S.G. Eur. J. Neurosci., 2002, 16, 1896.
39. Ogier, R.; Raggenbass, M. Eur. J. Neurosci., 2003, 17, 2639.
40. Mantyh, P.W.; DeMaster, E.; Malhotra, A.; Ghilardi, J.R.; Rogers, S.D.; Mantyh, C.R.; Liu, H.; Basbaum, A.I.; Vigna, S.R.; Maggio, J.E.; Simone, D.A. Science, 1995, 268, 1629.
41. Mantyh, P.W.; Hunt, S.P.; Maggio, J.E. Brain Res., 1984; 307, 147.
42. O'Donohue, T.L.; Helke, C.J.; Shults, C.W.; Buck, S.H.; Burcher, E. In Handbook of Chemical Neuroanatomy, Vol. 9: Neuropeptides in the CNS, Part II; Anders Björklund, Tomas Hökfelt, Michael J. Kuhar, Eds.; Elsevier Science Publishers B. V. Amsterdam, 1990, pp. 395-442.
43. Maeno, H.; Kiyama, H.; Tohyama, M. Mol. Brain Res., 1993, 18, 43
44. Nakaya, Y.; Kaneko, T.; Shigemoto, R.; Nakanishi, S.; Mizuno, N. J. Comp. Neurol., 1994, 347, 249.
45. Saffroy, M.; Torrens, Y.; Glowinski, J.; Beaujouan, J.-C. Neuroscience, 2003, 116, 761.
46. Hanley, M.R.; Sandberg, B.E.B.; Lee, C.M.; Iversen, L.L.; Brundish, D.E.; Wade, R. Nature, 1980, 286, 810.
47. Dam, T.-V.; Quirion, R. Peptides, 1986, 7, 855.
48. Mantyh, P.W.; Gates, T.; Mantyh, C.R.; Maggio, J.E. J. Neurosci., 1989, 9, 258.
49. Kus, L.; Mazzone, S.B.; Paxinos, G.; Geraghty, D.P. Brain Res., 1998, 794, 309.
50. Tooney, P.A.; Au, G.G.; Chahl, L.A. Neurosci. Lett., 2000, 283, 185
51. Hargreaves, R. J. Clin. Psychiatry, 2002, 63 (suppl. 11), 18.
52. Caberlotto, L.; Hurd, Y.L.; Murdock, P.; Wahlin, J.P.; Melotto, S.; Corsi, M.; Carletti, R. Eur. J. Neurosci., 2003, 17, 1736.
53. Vigna, S.R.; Bowden, J.J.; McDonald, D.M.; Fisher, J.; Okamoto, A.; McVey, D.C.; Payan, D.G.; Bunnett, N.W. J. Neurosci., 1994, 14, 834.
54. Conley, R.K.; Cumberbatch, M.J.; Mason, G.S.; Williamson, D.J.; Harrison, T.; Locker, K.; Swain, C.; Maubach, K.; O'Donnell, R.; Rigby, M.; Hewson, L.; Smith, D.; Rupniak, N.M.J. J. Neurosci., 2002, 22, 7730.
55. Stout, S.C.; Owens, M.J.; Nemeroff, C.B. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 877.
56. Papp, M.; Vassout, A.; Gentsch, C. Behav. Brain Res., 2000, 115, 19.
57. Takayama, H.; Ota, Z.; Ogawa, N. Regul. Pept., 1986, 15, 239.
58. Smith, D.W.; Hewson, L.; Fuller, P.; Williams, A.R.; Wheeldon, A.; Rupniak, N.M.J. Brain Res., 1999, 848, 90.
59. Barden, N.; Daigle, M.; Picard, V.; Di Paolo, T. J. Neurochem., 1983, 41, 834.
60. Brodin, E.; Ogren, S.O.; Theodorsson-Norheim, E. Neuropharmacology, 1987, 26, 581.
61. Riley, L.A.; Hart, R.P.; Jonakait, G.M. Mol. Cell. Neurosci., 1991, 2, 139.
62. Shirayama, Y.; Mitsushio, H.; Takashima, M.; Ichikawa, H.; Takahashi, K. Brain Res., 1996, 739, 70.
63. Baby, S.; Nguyen, M.; Tran, D.; Raffa, R.B. J. Clin. Pharm. Ther., 1999, 24, 461.
64. Bondy, B.; Baghai, T.C.; Minov, C.; Schille, C.; Schwarz, M.J.; Zwanzger, P.; Rupprecht, R.; Möller, H.-J. Biol. Psychiatry, 2003, 53, 538.
65. Rimon R.; Le Greves P.; Nyberg, F.; Heikkila L.; Salmela, L.; Terenius, L. Biol. Psychiatry, 1984, 19, 509.
66. Heikkila, L.; Rimon, R.; Terenius, L. Psychiatry Res., 1990, 34, 229.
67. Berrettini, W.H.; Rubinow, D.R.; Numberger, J.I.; Simmons-Alling, S.; Post, R.M.; Gershon, E.S. Biol. Psychiatry, 1985, 20, 965.
68. Arinami, T.; Li, L.; Mitsushio, H.; Itokawa, M.; Hamaguchi, H.; Toru, M. Biol. Psychiatry, 1996, 40, 1122.
69. Furlong, R.A.; Keramatipour, M.; Ho, L.W.; Rubinsztein, J.S.; Michael, A.; Walsh, C.; Paykel, E.S.; Rubinsztein, D.C. Am. J. Med. Gen., 2000, 96, 733.
70. Meira-Lima, I.V.; Pereira, A.C.; Mota, G.F.; Krieger, J.E.; Vallada, H. Neurosci. Lett., 2000, 293, 103.
71. Pauls, J.; Bandelow, B.; Kornhuber, J. J. Neural Transm., 2000, 107, 1361.
72. Hong, C.-J.; Wang, Y.-C.; Tsai, S.-J. J. Neural Transm., 2002, 109, 1209.
73. Burnet, P.W.J.; Harrison, P.J. Biol. Psychiatry, 2000, 47, 80.
74. Stockmeier, C.A.; Shi, X.; Konick, L.; Overholser, J.C.; Jurjus, G.; Meltzer, H.Y.; Friedman, L.; Blier, P.; Rajkowska, G. Neuroreport, 2002, 13, 1223.
75. Elliott, P.J. Exp. Brain Res., 1988, 73, 354.
76. Gradin, K.; Qadri, F.; Nomikos, G.G.; Hillegaart, V.; Svensson, T.H. Eur. J. Pharmacol., 1992, 218, 363.
77. Aguiar, M.S.; Brandão, M.L. Behav. Pharmacol., 1994, 5, 369.
78. Teixeira, R.M.; Santos, A.R.; Ribeiro, S.J.; Calixto, J.B.; Rae, G.A. Eur. J. Pharmacol., 1996, 311, 7.
79. Rupniak, N.M.J. Curr. Opin. Investig. Drugs, 2002, 3, 257.
80. Holmes, A.; Heilig, M.; Rupniak, N.M.J.; Steckler, T.; Griebel, G. Trends Pharmacol. Sci., 2003, 24, 580.
81. Rupniak, N.M.J.; Carlson, E.C.; Harrison, T.; Oates, B.; Seward, E.; Owen, S.; de Felipe, C.; Hunt, S.; Wheeldon, A. Neuropharmacology, 2000, 39, 1413.
82. Boyce, S.; Smith, D.; Carlson, E.; Hewson, L.; Rigby, M.; O'Donnell, R.; Harrison, T.; Rupniak, N.M.J. Neuropharmacology, 2001, 41, 130.
83. Santarelli, L.; Gobbi, G.; Debs, P.C.; Sibille, E.L.; Blier, P.; Hen, R.; Heath, M.J.S. Proc. Natl. Acad. Sci. USA, 2001, 98, 1912.
84. Rupniak, N.M.J.; Carlson, E.J.; Shepheard, S.; Bentley, G.; Williams, A.R.; Hill, A.; Swain, C.; Mills, S.G.; Di Salvo, J.; Kilburn, R.; Cascieri, M.A.; Kurtz, M.M.; Tsao, K.-L.; Gould, S.L.; Chicchi, G.G. Neuropharmacology, 2003, 45, 231.
85. File, S.E. Pharmacol. Biochem. Behav., 1997, 58, 747.
86. Rupniak, N.M.J.; Carlson, E.J., Webb, J.K.; Harrison, T.; Porsolt, R.D.; Roux, S.; de Felipe, C.; Hunt, S.P.; Oates, B.; Wheeldon, A. Behav. Pharmacol., 2001, 12, 497.
87. Zocchi A.; Varnier, G.; Arban, R.; Griffante, C.; Zanetti, L.; Bettelini, L.; Marchi, M.; Gerrard, P.A.; Corsi, M. Neurosci. Lett., 2003, 345, 73.
88. Zernig, G.; Dietrich, H.; Maggi, C.A.; Saria, A. Neurosci. Lett., 1992, 143, 169.
89. De Felipe, C.; Herrero, J.F.; O'Brien, J.A.; Palmer, J.A.; Doyle, C.A.; Smith, A.J.; Laird, J.M.; Belmonte, C.; Cervero, F.; Hunt, S.P. Nature, 1998, 392, 394.
90. Santarelli, L.; Gobbi, G.; Blier, P.; Hen, R. J. Clin. Psychiatry, 2002, 63 (suppl. 11), 11.
91. Duman, R.S.; Nakagawa, S.; Malberg, J. Neuropsychopharmacology, 2001, 25, 836.
92. Manev, H.; Uz, T.; Smalheiser, N.R.; Manev, R. Eur. J. Pharmacol., 2001, 411, 67.
93. Vaidya, V.A.; Duman, R.S. Br. Med. Bull., 2001, 57,61.
94. D'Sa, C.; Duman, R.S. Bipolar Disord., 2002, 4, 183.
95. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C.; Hen, R. Science, 2003, 301, 805.
96. Malberg, J.E.; Eisch, A.J.; Nestler, E.J.; Duman, R.S. J. Neurosci., 2000, 20, 9104.
97. Morcuende, S.; Gadd, C.A.; Peters, M.; Moss, A.; Harris, E.A.; Sheasby, A.; Fisher, A.S.; De Felipe, C.; Mantyh, P.W.; Rupniak, N.M.J.; Giese, K.P.; Hunt, S.P. Eur. J. Neurosci., 2003, 18, 1828.
98. van der Hart, M.G.; Czeh, B.; de Biurrun, G.; Michaelis, T.; Watanabe, T.; Natt, O.; Frahm, J.; Fuchs, E. Mol. Psychiatry, 2002, 7, 933.
99. Rupniak, N.M J.; Kramer, M.S. Trends Pharmacol. Sci., 1999, 20, 485.
100. Kramer, M.S. Neuropeptides, 2000, 34, 255.
101. Brown, W.A. Neuropsychopharmacology, 1994, 10, 265.
102. Khan, A.; Warner, H.A.; Brown, W.A. Arch. Gen. Psychiatry, 2000, 57, 311.
103. Kramer, M.S.; Winokur, A.; Kelsey, J.; Preskorn, S.H.; Rothschild, A.J.; Snavely, D.; Ghosh, K.; Ball, W.A.; Reines, S.A.; Munjack, D.; Apter, J.T.; Cunningham, L.; Kling, M.; Bari, M.; Getson, A.; Lee, Y. Neuropsychopharmacology, 2004, 29, 385.
104. Zhou, Q.; Nyberg, F. Neurosci. Lett., 2002, 320, 117.
105. Lejeune, F.; Gobert, A.; Millan, M.J. Brain Res., 2002, 935, 134.
106. Froger, N.; Gardier, A.M.; Moratalla, R.; Alberti, I.; Lena, I.; Boni, C.; De Felipe, C.; Rupniak, N.M.J.; Hunt, S.P.; Jacquot, C.; Hamon, M.; Lanfumey, L. J. Neurosci., 2001; 21, 8188.
107. Commons, K.G.; Valentino, R.J. J. Comp. Neurol., 2002, 447, 82.
108. Léger, L.; Gay, N.; Cespuglio, R. Neurosci. Lett., 2002, 323, 146.
109. Liu, R.; Ding, Y.; Aghajanian, G.K. Neuropsychopharmacology, 2002, 27, 329.
110. Commons, K.G.; Connolley, K.R.; Valentino, R.J. Neuropsychopharmacology, 2003, 28, 206.
111. Jolas, T.; Aghajanian, G.K. Brain Res., 1997, 755, 229.
112. Valentino, R.J.; Bey, V.; Pernar, L.; Commons, K.G. J. Neurosci., 2003, 23, 7155.
113. Haddjeri, N.; Blier, P. Biol. Psychiatry, 2001, 50, 191.
114. Guiard, B.P.; Froger, N.; Hamon, M.; Gardier, A.M.; Lanfumey, L. Soc. Neurosci. Abstr., 2003, 460, 4.
115. Maubach, K.A.; Martin, K.; Chicchi, G.; Harrison, T.; Wheeldon, A.; Swain, C.J.; Cumberbatch, M.J.; Rupniak, N.M.J.; Seabrook, G.R. Neuroscience, 2002, 109, 609.
116. Haddjeri, N.; Blier, P. Neuroreport, 2000, 11, 1323.
117. Peyron, C.; Luppi, P.H.; Fort, P.; Rampon, C.; Jouvet, M. J. Comp. Neurol., 1996, 364, 402.
118. Chen, L.W.; Wei, L.C.; Liu, H.L.; Roa, Z.R. Brain Res., 2000, 873, 155.
119. Shen, K.Z.; North, R.A. Neuroscience, 1992, 50, 345.
120. Koyano, K.; Velimirovic, B.M.; Grigg, J.J.; Nakajima, S.; Nakajima, Y. Eur. J. Neurosci., 1993, 5, 1189.
121. Millan, M.J.; Lejeune, F.; De Nanteuil, G.; Gobert, A. J. Neurochem., 2001, 76, 1949.
122. Jakab, R.L.; Goldman-Rakic, P.S. J. Comp. Neurol., 2000, 417, 337.
123. Hajós, M.; Richards, C.D.; Székely, A.D.; Sharp, T. Neuroscience, 1998, 87, 95.
124. Martín-Ruiz, R.; Puig, M.V.; Celada, P.; Shapiro, D.A.; Roth, B.L.; Mengod, G.; Artigas, F. J. Neurosci., 2001, 21, 9856.
125. Celada, P.; Puig, M.V.; Casanovas, J.M.; Guillazo, G.; Artigas, F. J. Neurosci., 2001, 21, 9917.
126. Amargós-Bosch, M.; Adell, A.; Bortolozzi, A.; Artigas, F. J. Neurochem., 2003, 87, 831.
127. Varga, V.; Kocsis, B.; Sharp, T. Eur. J. Neurosci., 2003, 17, 280.
128. Guiard, B.; Seyler, S.; Jego, -G.; Przybylski, C.; Gardier, A.M. Soc. Neurosci. Abstr., 2002, 646, 8.
129. Lejeune, F.M.; Gobert, A.; Millan, M. Soc. Neurosci. Abstr., 2003, 889, 22.
130. Betancur, C.; Azzi, M.; Rostène, W. Trends Pharmacol. Sci., 1997, 18, 372.
131. Hökfelt, T.; Bartfai, T.; Bloom, F. Lancet Neurol., 2003, 2, 463.
132. Aston-Jones, G.; Ennis, M.; Pieribone, V.A.; Nickel, W.T.; Shipley, M.T. Science, 1986, 234, 734.
133. Pammer, C.; Görcs, T.; Palkovits, M. Brain Res., 1990, 515, 247.